Comprehensive analysis of the TCGA and Oncomine databases revealed that GPX4 was more highly expressed in most cancers, such as COAD, STAD, LIHC, ESCA, and KIRC, than in normal tissues (Fig. 1A, Fig. S1A). Here, GPX4 is linked to cancer.